MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN.
第一作者:
S L,Cohn
第一单位:
Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois, USA. scohn@northwestern.edu
作者:
主题词
印迹法, 蛋白质(Blotting, Western);队列研究(Cohort Studies);女(雌)性(Female);基因扩增(Gene Amplification);基因表达(Gene Expression);基因, myc(Genes, myc);人类(Humans);婴儿(Infant);男(雄)性(Male);肿瘤分期(Neoplasm Staging);神经母细胞瘤(Neuroblastoma);预后(Prognosis);原癌基因蛋白质c-myc(Proto-Oncogene Proteins c-myc);RNA, 信使(RNA, Messenger);结果可重复性(Reproducibility of Results);逆转录聚合酶链反应(Reverse Transcriptase Polymerase Chain Reaction);存活率分析(Survival Analysis)
DOI
10.1200/JCO.2000.18.21.3604
PMID
11054433
发布时间
2017-02-10
- 浏览22

Journal of clinical oncology
3604-13页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文